BeiGene
BeiGene is developing a pipeline of oral small molecules and monoclonal antibodies to fight cancer. Get up to date with the BeiGene solid tumor pipeline and clinical trials.
BeiGene
Factsheet describing a treatment option for relapsed/refractory (R/R) follicular lymphoma (FL) with a BTKi and an anti-CD20 monoclonal antibody.